Search Results - "Mikanda KK"

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial.

Authors: Guglielmetti L Khan U Velásquez GE et al.

Corporate Authors: Guglielmetti L Khan U Velásquez GE et al.

Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2025 Sep; Vol. 13 (9), pp. 809-820. Date of Electronic Publication: 2025 Jul 16.

Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE